Insiders Matinas BioPharma Holdings, Inc.

Equities

MTNB

US5768101058

Delayed Nyse Other stock markets 20:46:05 13/05/2024 BST			5-day change	1st Jan Change
0.17 ^USD	-3.19%		+1.73%	-20.95%

05-09	Transcript : Matinas BioPharma Holdings, Inc., Q1 2024 Earnings Call, May 09, 2024
05-09	Matinas BioPharma Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Matinas BioPharma Promotes Eric J. Ende as Chairman of the Board	21/09/22	MT
Matinas BioPharma Holdings, Inc. Announces Board Changes, Effective October 1, 2022	21/09/22	CI
Matinas BioPharma Holdings, Inc. Announces Retirement of Raphael J. Mannino, Chief Scientific Officer, Effective December 31, 2022	11/08/22	CI
Matinas BioPharma Holdings Names Chief Business Officer	06/12/21	MT
Matinas BioPharma Appoints Thomas Hoover, M.B.A. as Chief Business Officer	06/12/21	CI
Matinas BioPharma Holdings, Inc. Elects Kathryn Corzo to the Board of Directors	01/11/21	CI
Matinas Biopharma Holdings, Inc. Announces Resignation of Patrick Le Pore as Director	17/09/21	CI
Matinas BioPharma Holdings, Inc. Announces FDA Conditional Acceptance of LYPDISO™ as the Brand Name for MAT9001	04/01/21	CI
Matinas BioPharma Holdings, Inc. Appoints Hui Liu as Chief Technology Officer	01/12/20	CI
Matinas BioPharma Holdings, Inc. Announces Change of Board of Directors	14/09/20	CI
Matinas Biopharma Holdings, Inc. Appoints James A. Underberg M.D., M.S., Facpm, Facp, Fnyam, Faspc, Fnla to Its Scientific Advisory Board	04/03/20	CI
Matinas Biopharma Holdings, Inc. Appoints James J. Ferguson as Its Chief Medical Officer	25/02/19	CI
Matinas BioPharma Holdings, Inc. Appoints Keith Kucinski as Chief Financial Officer	03/01/19	CI
Matinas BioPharma Appoints Harold E. Bays, M.D. to its Cardiovascular Health Scientific Advisory Board	19/12/18	CI
Matinas BioPharma Holdings, Inc. Establishes A New Scientific Advisory Board	06/12/18	CI
Matinas BioPharma Holdings, Inc. Announces Executive Appointments	15/10/18	CI
Matinas BioPharma Holdings, Inc. Appoints Patrick G. Lepore as Vice Chairman to its Board of Directors	06/09/18	CI
Matinas Biopharma Holdings, Inc. Announces Termination of Dominick M. Dipaolo as Its Senior Vice President of Quality and Regulatory Compliance	18/06/18	CI
Matinas BioPharma Announces Executive Changes	16/03/18	CI
Matinas BioPharma Holdings, Inc. Announces Board Changes, Effective January 1, 2018	14/12/17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Matinas BioPharma Holdings, Inc.

Equities

MTNB

US5768101058

Insiders

Filters